- Volume 17 Issue 8
DOI QR Code
Clinico-Hematological Findings for Classical Hodgkin's Lymphoma: an Institutional Experience
- Sultan, Sadia (Department of Hematology & Blood bank, Liaquat National Hospital and Medical College) ;
- Irfan, Syed Mohammed (Department of Hematology & Blood bank, Liaquat National Hospital and Medical College) ;
- Parveen, Saira (Department of Hematology & Blood bank, Liaquat National Hospital and Medical College) ;
- Ali, Saif (Liaquat National Medical College)
- Published : 2016.08.01
Background: Classical Hodgkin's lymphoma (cHL) is a B-cell lymphoid neoplasm characterized by a distinctive biological behavior with potentially curable disease characteristics. It is an uncommon hematological malignancy which primarily affects younger individuals. The rationale of this study was to determine its clinico-hematological profile along with stage stratification in Pakistani patients. Materials and Methods: In this descriptive study, adult patients with Hodgkin's lymphoma were enrolled from January 2010 to December 2014. Results: Sixty two histopathologically confirmed cases of cHL were identified. There were 42 males and 20 females, with a male to female ratio of 2: 1. The mean age was
- Ansell SM (2015). Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc, 90, 1574-83. https://doi.org/10.1016/j.mayocp.2015.07.005
- Butt F, Akhtar R, Rahmani T, et al (2002). Bone marrow involvement in lymphoma: Incidence and co-relation with age and sex. Biomedica, 18 , 53-7.
- Fatima S, Ahmed R, Ahmed A (2011). Hodgkin lymphoma in Pakistan: an analysis of subtypes and their correlation with Epstein Barr virus. Asian Pac J Cancer Prev, 12, 1385-8.
- Ganesan P, Kumar L, Raina V (2011). Hodgkin's lymphomalong- term outcome: an experience from a tertiary care cancer center in North India. Ann Hematol, 90, 1153-60. https://doi.org/10.1007/s00277-011-1262-8
- Gad Allah H, El-Azzazi MO, Elafifi AM, et al (2014). Treatment outcome in Egyptian lymphoma patients, 2-year results, single-center experience. Egypt J Haematol, 39, 209-16. https://doi.org/10.4103/1110-1067.153957
- Grover NS, Park SI (2015). Novel targeted agents in hodgkin and non-Hodgkin lymphoma therapy. Pharmaceuticals, 8, 607-36. https://doi.org/10.3390/ph8030607
- Gutensohn N, Cole P (1981). Childhood social environment and Hodgkin's disease. N EngL J Med, 304, 135-40. https://doi.org/10.1056/NEJM198101153040302
- Hamid A, Hamid Am, Jabbar N, et al (2010). Significance of bone marrow biopsy in staging of Hodgkin's lymphoma. Ann King Edward Med University, 16, 12-16.
- Hodgkin (1832). On some morbid appearances of the absorbent glands and spleen. Med Chir Trans, 17, 68-114.
- Jalali A, Ha FJ, Chong G, et al (2016). Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era. Ann Hematol, [Epub ahead of print]
- Khan G, Norton AJ, Slavin G, (1993). Epstein Barr virus in Hodgkin's disease: Relation to age and subtype. Cancer, 71, 3124-9. https://doi.org/10.1002/1097-0142(19930515)71:10<3124::AID-CNCR2820711038>3.0.CO;2-J
- Koren J, Trneny M (2015). Hodgkin's lymphoma - the treatment approaches development and current trends. Klin Onkol, 28, 387-94. https://doi.org/10.14735/amko20153S87
- Li X, Yang SE, Guo YQ, et al (2012). Clinical significance of quantitative analysis of plasma epstein- barr virus DNA in patients of Xinjiang Uygur nationality with Hodgkin's Lymphoma. Asian Pac J Cancer Prev, 13, 6379-84. https://doi.org/10.7314/APJCP.2012.13.12.6379
- Lone A, Naeem S (2011). Frequency and pattern of bone marrow infiltration in Hodgkin's Lymphoma. Biomedica, 27, 132-5.
- MacFarlane GL, Evstifeeva T, Boyle P, et al (1995). International patterns in the occurrence of Hodgkin’s disease in children and young adult males. Int J Cancer, 61, 165-9. https://doi.org/10.1002/ijc.2910610204
- Matteo ED, Baron AV, Chabay P, et al (2003). Comparison of Epstein Barr virus presence in Hodgkin’s lymphoma in pediatric versus adult Argentine patients. Arch Pathol Lab Med, 127, 1325-9.
- Maddi RN, Linga VG, Iyer KK, et al (2015). Clinical profile and outcome of adult Hodgkin lymphoma: Experience from a tertiary care institution. Indian J Med Paediatr Oncol, 36, 255-60. https://doi.org/10.4103/0971-5851.171550
- Nagi AH, Al-Menawy LA, Samiullah, et al (2008). A comparison of histological appearances of Hodgkin’s disease in Pakistani and Saudi patients. J Ayub Med Coll Abbottabad, 20, 66-9.
- Roshandel G, Semnani S, Aarabi M, et al (2011). Lymphomas in Golestan province of Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 12, 219-22.
- Sader-Ghorra C, Rassy M, Naderi S, et al (2014).Type distribution of lymphomas in Lebanon: five-year single institution experience. Asian Pac J Cancer Prev, 15, 5825-8. https://doi.org/10.7314/APJCP.2014.15.14.5825
- Siddiqui N, Ayub B, Badar F, et al (2006). Hodgkin's lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore. Asian Pac J Cancer Prev, 7, 651-5.
- Swerdlow SH, Campo E, Harris NL, et al (2008). WHO classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid Tissues. Lyon: IARC Press. pp. 321-34.
- Tang Y, Sun LG, Liu CS, et al (2013). Clinical analysis of stages of HBV infection in 100 cases of lymphoma. Asian Pac J Cancer Prev, 14, 959-62. https://doi.org/10.7314/APJCP.2013.14.2.959
- Waravita TS, Wijetunge TS, Ratnatunga NV (2015). Pattern of lymphoma subtypes in a cohort of Sri Lankan patients. Ceylon Med J, 60, 13-7. https://doi.org/10.4038/cmj.v60i1.7143
- Yung L, Linch D (2003). Hodgkin's lymphoma. Lancet, 361, 943-51. https://doi.org/10.1016/S0140-6736(03)12777-8